Chemical synthesis of a fully active transcriptional repressor protein by Solar, Gloria del et al.
Proc. Natl. Acad. Sci. USA
Vol. 91, pp. 5178-5182, May 1994
Biochemistry
Chemical synthesis of a fully active transcriptional
repressor protein
(affnity purdficton/gel retardation asays/in vitro ftrascription)
GLORIA DEL SOLAR*t, FERNANDO ALBERICIOt, RAM6N ERITJA§, AND MANUEL ESPINOSA*
*Centro de Investigaciones Biol6gicas, Consejo Superior de Investigaciones Cientificas, Velizquez, 144, E-28006 Madrid, Spain; tLife Sciences Research
Group, Millipore Corporation, Bedford, MA 01730; and Centro de Investigaci6n y Desarrollo, Consejo Superior de Investigaciones Cientificas, Jordi Girona,
18, E-8034 Barcelona, Spain
Communicated by Donald R. Helinski, January 28, 1994
ABSTRACT Plasmid pLSl-encoded 45-amino acid tran-
scriptional repressor CopG (formerly RepA) has been chemi-
cafly synthesized. A one-step purification of the synthetic
protein has been developed, which yields high levels of pure
protein with low or no contamination of tructed products.
We have compared some properties of the chemical CopG
protein with those of the bidogicafly purified CopG. The two
proteins were indistinguishable in (t) their ability to generate
specific protein-DNA complexes, (it) their capacity to protect
a restriction site inciuded within the CopGDNA target, and (iU)
in their in vitro capacity to specificafly repress synthesis ofcopG
mRNA.
Modulation ofgene expression from a given promoter can be
mediated by DNA-binding proteins. Such transcriptional
control is achieved through various mechanisms, including
long-distance DNA-protein and protein-protein interactions
(refs. 1 and 2; reviewed in ref. 3), protein-mediated curva-
tures in regions upstream of promoters (4, 5), and steric
hindrance ofthe binding ofRNA polymerase to the promoter.
The generation of local DNA deformations in the promoter
region (6, 7) or contacts between the DNA-binding protein
and RNA polymerase can also modulate promoter activity
(8). Information on DNA-protein complexes can be obtained
from gel retardation assays (9) or through a variety of
"footprinting" techniques (10). However, the determination
of the conformation of the complexes usually is the ultimate
goal (11). Such information can be comprehensive if it is
accompanied by mutational analysis, which is facilitated
when genetic systems designed to select the desired muta-
tions are available (12, 13). However, laborious procedures of
overproduction and purification of the mutant proteins are
often still required.
One way to overcome these difficulties is to attempt the
chemical synthesis of all or a part of the desired protein.
However, these procedures often do not yield active prod-
ucts, especially when a certain peptide size is surpassed. We
have developed a procedure to chemically synthesize and
purify a well-characterized transcriptional repressor and we
have tested the activity of the final product. To this end, we
have combined our knowledge of the properties of the CopG
repressor (formerly RepA; ref. 14) with the advantages of
9-fluorenylmethoxycarbonyl (Fmoc) chemistry. This chem-
ical procedure has been improved, and a one-step purification
method has been developed (15). We report the complete
chemical synthesis of the plasmid pLS1-encoded transcrip-
tional repressor CopG by a relatively simple method which
yields milligrams of highly pure and fully active protein. Our
findings open avenues for the analysis of protein structure
and function and for the generation of custom-made protein
mutants.
MATERIALS AND METHODS
DNA Isolation and Manipulations. The plasmid used was
pLS1A24, an in vitro clockwise deletion derivative (including
coordinates 4240-401) of plasmid pLS1 (16). Plasmid DNA
was prepared from Streptococcus pneumoniae and purified
by two consecutive CsCl/ethidium bromide gradients, es-
sentially as described (14). Digestions of DNA with restric-
tion enzymes (New England Biolabs) were performed as
specified by the supplier. Restriction fragments were purified
from 0.8% agarose gels with the Geneclean kit (Bio-101).
Purification of CopG from a Biologcl Source. CopG (for-
merly RepA; ref. 14) protein was overproduced with the
Escherichia coli BL21(DE3) host/pET5 vector expression
system (17). The copGgene was overexpressed afterinduction
with isopropyl (3-D-thiogalactopyranoside, and its product was
purified by chromatography on agarose and heparin-agarose
columns, as described (14). A further step of purification and
concentration was achieved by a second heparin-agarose
column, using a 0.1-1 M NaCl gradient. Concentration of the
purified CopG protein used here was 20 Ag/ml, as calculated
by determination of CopG amino acid composition.
Chemical Synthesis of CopG. Chain assembly was carried
out on a Millipore 9050 Plus automated peptide continuous-
flow synthesizer, starting with a Fmoc-Lys(Boc)-PAC-
PEG-PS resin (Millipore; ref. 18), where Boc is tert-
butyloxycarbonyl, PAC is a peptide acid linker, PEG is a
polyethylene glycol spacer, and PS is the styrene/1% divi-
nylbenzene copolymer constituting the resin beads. The
required Fmoc-amino acids (5 equivalents) were incorpo-
rated by 1- to 2-hr couplings (as the synthesis progressed,
coupling times were extended) mediated by benzotriazolyl
N-oxytris(pyrrolidinio)phosphonium hexafluorophosphate/
1-hydroxybenzotriazole/N,N-diisopropylethylamine (5, 5,
and 10 equivalents, respectively) in NN-dimethylform-
amide. Deprotection of the Fmoc group was done with
1,8-diazabicyclo[5.4.0]undec-7-ene/piperidine-N,N-dimeth-
ylformamide, 2:2:% (vol/vol), for 7-12 min. After each
coupling, an acetylation step with 0.3M acetic anhydride and
0.3 M N,N-diisopropylethylamine in NN-dimethylforma-
mide for 10 min was carried out to block the unreacted amino
groups and therefore to facilitate the final purification. After
removal of the Fmoc group from the last amino acid, Bio-
linker S-Trt [S-(trityl)thioglycolylaminoethylsulfonylethyl
p-nitrophenyl carbonate; 2 equivalents; Nikkon Millipore,
Tokyo; ref. 15] was incorporated into the amino-terminal
function in the presence of 1-hydroxybenzotriazole (2 equiv-
Abbreviations: Fmoc, 9-fluorenylmethoxycarbonyl; B-CopG, bio-
logically produced CopG; Ch-CopG, chemically synthesized CopG.
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alents) in N,N-dimethylformamide for 2 hr at 250C. Cleavage
of the peptide from the resin was done by reagent R (tri-
fluoroacetic acid/thioanisole/ethanedithiol/anisole,
90:5:3:2) for 2 hr at 25TC (19). The resulting sulflhydryl-
containing peptide was dissolved in 6 M guanidine hydro-
chloride/0.4 M Tris-HCl, pH 7.5, and mixed with an iodoac-
etamide resin (=1.1 equivalents; Nikkon Millipore, Tokyo),
for 2 hr at 250C. In this step only the desired peptide
possessing the sulflydryl group was immobilized by covalent
bonding to the resin. Then, 1 equivalent of2-mercaptoethanol
was added for 30 min at 25°( to block the remaining iodo-
acetamide groups. The solution was filtered off, and the resin
was washed with acetic acid/water, 1:1, and with methanol.
The target peptide was released by treatment ofthe resin with
aqueous 5% NH40H for 2 hr at 250C and the solution was
filtered off. The resin was then washed twice with aqueous
5% NH4OH. The combined washings were lyophilized. The
overall yield (synthesis and purification) was 5%.
Gel Retardation Assays. Plasmid pLS1A24 DNA was dou-
bly digested with Fnu4HI and Sty I to give fragments of 1327,
1287, 753, 252, 123, 93, and 3 bp. The target of CopG is
included within the 252-bp fragment, and is located --100 bp
from both ends. DNA (20 nM) was incubated with various
concentrations ofCopG proteins for 10 min at 20°C in 20 mM
Tris HCl, pH 8.0/1 mM EDTA/5 mM dithiothreitol. Reac-
tion mixtures were loaded on nondenaturing 5% polyacryl-
amide gels, electrophoresed at 10 V/cm, stained, and pho-
tographed. Several pictures of the same gel, with different
exposure times, were taken, and the negatives were used for
densitometric scannings.
CopG Protection of ApaLI Restriction Site. Plasmid
pLS1A24 DNA was linearized with EcoRI (coordinate 3170),
phenol-treated, and precipitated. DNA (6.5 nM) was incu-
bated (final volume, 15 p1) with various amounts of CopG
proteins for 10 min at 20°C in ApaLI buffer (10mM Tris HCl,
pH 8.0/50mM KC1/7 mM MgCl2/7 mM 2-mercaptoethanol).
Then 6 units of ApaLI (which cuts at pLS1 coordinate 607)
was added, and the incubation was continued at 37°C for 25
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min. Reaction mixtures were electrophoresed in 1% agarose
gels, stained, and photographed as above.
In Vitro Transcription Assays. Transcripts were synthesized
in vitro from the 842-bp Ban I-Pst I pLS1 fragment (coordi-
nates 214-1056), which contains two promoters: Pcr and Pct.
The Pcr promoter contains the CopG target, whereas the Pct
promoter (used as internal control) is not repressed by CopG.
Reaction mixtures (50 A) contained 40 mM Tris'HCl (pH 8.0),
10 mM MgC2, 150 mM KCl, 0.1 mM EDTA, 5% (vol/vol)
glycerol, 200 ,uM GTP, 200 pM ATP, 50 ,uM CTP, 50 ,M[a-32P]UTP (4 Ci/mmol; 1 Ci = 37 GBq) and S nM DNA
fragment. Transcription was initiated by the addition of 0.15
unit of Escherichia coli RNA polymerase, and samples were
incubated for 10 min at 37°C. When CopG proteins were used,
mixtures were incubated with the proteins for 10 min at 20°C
before the addition ofRNA polymerase. Samples were treated
and electrophoresed as described (20).
RESULTS AND DISCUSSION
The protein synthesized, CopG, is the smallest natural tran-
scriptional repressor so far described (20). It is encoded by
H-Met-Lys-Lys-Arg-Leu-Thr-lle-Thr-Leu-Ser-Glu-Ser-
-Val-Leu-Glu-Asn-Leu-Glu-Lys-Met-Ala-Arg-Glu-Met-
-Gly-Leu-Ser-Lys-Ser-Ala-Met-ille-Ser-Val-Ala-Leu-
-Glu-Asn-Tyr-Lys-Lys-Gly-Gln-Glu-Lys-H
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FIG. 1. Relevant features of plasmid pLS1. (A) Schematic map
with relevant restriction sites. (B) The PT promoter, within which a
13-bp symmetric element (symmetric bases are underlined; arrow
points to the center of symmetry) and a single ApaLI restriction site
are included. The transcription initiation site (arrowhead), the pu-
tative ribosome-binding (Shine-Dalgarno, S.D.) site, and the first
two codons of CopG are indicated. (C) Schematic representation of
the putative helix-turn-helix motif of CopG (residues 17-36).
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FIG. 2. Composition and synthesis of CopG. (Top) Amino acid
composition ofCopG, as determined by automatic sequencing ofthe
biologically synthesized protein (14). (Middle and Bottom) HPLC of
crude preparation and Bio-linker purification step, respectively.
HPLC conditions: C18 resin; elution with a 20-min linear gradient
from 1:9 to 6:4 of 0.1% trifluoroacetic acid/acetonitrile vs. 0.1%
trifluoroacetic acid/water; flow rate, 1 ml/min.
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FIG. 3. Features of CopG. (A) General properties of B-CopG, as
derived from a number ofphysicochemical analyses. (B) Comparison
of electrophoretic mobility and purity of chemically synthesized
CopG (Ch-CopG) and B-CopG in a denaturing SDS/17% polyacryl-
amide gel stained with Coomassie brilliant blue.
the promiscuous plasmid pLS1 (Fig. 1; ref. 16), but similar
repressors have been described for several other bacterial
plasmids (14, 20). CopG is a fully sequenced 45-amino acid
polypeptide (14), which controls the synthesis of the plasmid
initiator of replication, the RepB protein, and thus controls
plasmid copy number (14, 21). The copG and repB genes are
cotranscribed from the Pcr promoter, which is included in the
target of CopG (20). The CopG target also includes a 13-bp
symmetric element which overlaps the -35 region of the Pcr
promoter (Fig. 1). Due to its small size, the predicted
structure of CopG is simple: one P3-sheet at the N terminus,
the helix-turn-helix motif typical of many DNA-binding
proteins (22, 23), and a positively charged random-coil C
terminus (14). The DNA region protected by purified CopG
protein spans 45 bp, which may be due either to the strong
DNA bend introduced by CopG around the Pcr promoter (24)
or to a very high cooperative binding of CopG to its target
DNA, perhaps mediated by protein-protein interactions (20).
These kinds of interactions, leading to dimer or tetramer
formation, seem to be a key feature for an efficient regulatory
role of the lac repressor (LacR), and they should be consid-
ered for any oligomeric DNA-binding protein (25).
Chemical synthesis of the entire CopG protein is proble-
matic because of the length of the sequence, the presence of
four methionine residues (Fig. 2), and the strong tendency of
the protein to bind to the purification supports, yielding low
or no recovery. In fact, several solid-phase syntheses based
upon the methodology developed by Merrifield (26) were
attempted with various chemistries without any significant
recovery of the protein. This contrasts with the results
obtained for the LacR-(1-56) headpiece (27), perhaps due to
the positively charged C end of CopG, or to the greater
methionine content ofCopG (four residues) as compared with
the truncated LacR synthetic peptide (two residues). Finally,
a successful synthesis was achieved with a Fmoc/tBu mild-
orthogonal scheme (28). After the cleavage of the peptide
from the resin, a chemical purification was carried out by
using an affinity-type purification procedure based upon the
specific reaction between the sulfhydryl group contained in
the peptide and an iodoacetamide group linked to a solid
support (15). The use of this purification method is critical
because it yields relatively homogeneous material in a single
step with excellent recoveries (Fig. 2).
Analysis of some properties of the biologically produced
CopG (B-CopG) protein (Fig. 3A) showed that it purifies as
a dimer of identical subunits, which agrees with the twofold
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FIG. 4. Interaction of Ch-CopG and B-CopG with the DNA
target. (A) CopG-DNA complex formation analyzed by gel retarda-
tion assays. DNA (20 nM) doubly digested with Fnu4HI and Sty I
(size of the fragments is indicated on the left) was incubated with
chemical or biological CopG protein (at the indicated nanomolar
concentrations). DNA-protein complexes formation was analyzed in
nondenaturing 5% polyacrylamide gels. The band containing the
CopG target is indicated (arrow). (B) Specific protection of the
ApaLI site of pLS1 by chemical and biological CopG proteins. DNA
(6.5 nM) linearized with EcoRI was incubated with the indicated
nanomolar concentrations ofchemical or biological CopG. The DNA
was then subjected to restriction with ApaLI, followed by electro-
phoresis in 1% agarose gels. The sizes of the linear and doubly
digested DNA are indicated. MW1 and MW2, "molecular weight"
standards.
symmetry of the CopG target (Fig. 1). The entire amino acid
sequence of B-CopG has been determined (14), which al-
lowed us a precise determination ofits molecular weight (Fig.
3A). A reliable estimation on the molar concentration of the
purified B-CopG protein resulted from the analysis of its
amino acid composition. The molar extinction coefficient of
CopG could not be measured, because the single aromatic
residue of the protein was not enough to obtain absorbance
information by simple methods. Several amounts of Ch-
CopG from the main peak of the chromatogram after Bio-
linker purification (Fig. 2) were run in a 17% polyacrylamide
denaturing gel (Fig. 3B) and compared with a known amount
of B-CopG (determined as indicated above). Densitometric
scanning of the gel allowed us to calculate that the total
amount ofpure Ch-CopG obtained was 200 Zg. Scaling up the
procedure gave milligam amounts of purified Ch-CopG. No
significant contamination of the chemical protein with trun-
cated peptides was found (Fig. 3B), indicating that the
synthesis procedure can yield crystallographic-quality puri-
fied protein.
To find out whether the Ch-CopG protein retained its
activity in the formation of specific DNA-protein complexes,
we compared the behavior of the two purified CopG proteins
by two in vitro assays. First, gel retardation showed that both
proteins efficiently and specifically bound to a 252-bp pLSl
B
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FIG. 5. Specific inhibition of RNA synthesis from the Pcr pro-
moter by chemical and biological CopG proteins. Concentration of
DNA in reaction mixtures was 5 nM; concentrations of CopG (nM)
are indicated above each lane. The four rightmost lanes show a
marker DNA sequence. Run-off transcripts above Pr are probably
due to artifacts generated by the protruding ends of the DNA
fragments.
DNA fragment containing the target ofCopG (Fig. 4A). Three
or four orders of CopG-DNA complexes were found, and
their generation depended upon the DNA/protein ratio em-
ployed. However, 2 times more Ch-CopG than B-CopG was
needed to obtain total specific complex formation. At high
protein concentration, smearing of the larger bands was
observed. This could be due to nonspecific binding rather
than overloading artifacts, since the smallest fragments were
unaffected (Fig. 4A).
The second assay was aimed at showing CopG protection
of the single pLSl ApaLI site, which is partially included
within the 13-bp symmetric element (Fig. 1). Full protection
of the restriction site was obtained with both proteins (Fig.
4B), and again twice as much Ch-CopG as B-CopG was
needed to achieve the same level of protection. The above
results indicate that Ch-CopG has about 50%6 activity as
compared with the B-CopG protein. Densitometric scanning
of the gels allowed us to obtain a rough estimation of the Kd
of both proteins, which was in the range of at least 10-9 M
(assuming the active fraction of the proteins to be 1). A DNA
fiagment containing the symmetric element and the ApaLI
restriction site ofpLSl, surrounded by foreign DNA, showed
low affinity for CopG (data not shown), indicating that
adjacent pLSl sequences are needed for good CopG-DNA
target recognition.
Functionality of Ch-CopG was assayed by comparing the
ability of Ch- and B-CopG proteins to act as specific tran-
scriptional repressors in vitro. For this purpose, we used a
pLS1 DNA fragment containing two promoters: Pcr (contain-
ing the CopG target; Fig. 1) and P~tu (from which a plasmid-
encoded 50-nt-long antisense RNA is transcribed; ref. 21).
Analysis of transcripts synthesized in the presence or in the
absence of the repressors showed that run-off transcripts
from Pcr were specifically inhibited by both types of CopG
protein, whereas the production of full transcripts from
promoter Pctu was unaffected by the presence of either
protein (Fig. 5). We conclude that only promoter Pc, is fully
and specifically repressed by both CopG proteins.
The results presented here show that the chemical synthesis
of an active protein is a powerful tool for the analysis of
DNA-protein interactions. The behaviors of Ch-CopG and
B-CopG were indistinguishable, both in the generation of
DNA-protein complexes and in their ability to repress tran-
scription from the copG promoter. The chemical procedure
used does not seem to affect the dimerization of CopG and
allows proper folding of this chemically prepared protein.
Moreover, the proposed chemical structure ofCopG, obtained
by protein isolation, purification, and sequencing (14), has
been confirmed here by the classical scheme of unambiguous
synthesis that yields a fully active protein. Since CopG is the
smallest transcriptional repressor known, this should be a
good model system to perform "mutational" studies by direct
synthesis coupled with structural determinations by nuclear
magnetic resonance spectrometry. Synthesis of specifically
designed Ch-CopG mutants may lead to a rapid characteriza-
tion of critical residues involved in DNA recognition. This in
turn would allow the design of a specific DNA site-directed
mutagenesis program to correlate in vitro activities of Ch-
CopG mutants with their in vivo functional roles.
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